173 related articles for article (PubMed ID: 19562438)
1. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
Shibata H; Nomori H; Uno K; Iyama K; Tomiyoshi K; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
Ann Nucl Med; 2009 Sep; 23(7):609-16. PubMed ID: 19562438
[TBL] [Abstract][Full Text] [Related]
2. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
[TBL] [Abstract][Full Text] [Related]
3. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
Watanabe K; Nomori H; Ohtsuka T; Naruke T; Ebihara A; Orikasa H; Yamazaki K; Uno K; Kobayashi T; Goya T
Jpn J Clin Oncol; 2006 Jul; 36(7):403-9. PubMed ID: 16782729
[TBL] [Abstract][Full Text] [Related]
4. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K
Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837
[TBL] [Abstract][Full Text] [Related]
5. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
[TBL] [Abstract][Full Text] [Related]
6. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
[TBL] [Abstract][Full Text] [Related]
8. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
Kaji M; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Ann Thorac Surg; 2007 Jan; 83(1):312-4. PubMed ID: 17184694
[TBL] [Abstract][Full Text] [Related]
9. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
[TBL] [Abstract][Full Text] [Related]
10. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
Vesselle H; Salskov A; Turcotte E; Wiens L; Schmidt R; Jordan CD; Vallières E; Wood DE
J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
[TBL] [Abstract][Full Text] [Related]
14. [Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Liu Y; Wu N; Bi GC; Zhang DS; Zheng R; Liang Y; Zhang WJ; Li XM; Fang Y
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):263-9. PubMed ID: 27087372
[TBL] [Abstract][Full Text] [Related]
15. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
[TBL] [Abstract][Full Text] [Related]
16. Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.
Saisho S; Yasuda K; Maeda A; Yukawa T; Okita R; Hirami Y; Shimizu K; Nakata M
Ann Nucl Med; 2013 Jul; 27(6):515-22. PubMed ID: 23504519
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Ohtsuka T; Nomori H; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Cancer; 2006 Nov; 107(10):2468-73. PubMed ID: 17036361
[TBL] [Abstract][Full Text] [Related]
18. [Biodistribution and positron emission tomography imaging of 11C-acetate in murine model of lung carcinoma].
Liang CY; Liu X; Zhang JM; Zhou NK; Zhang T; Liu HF
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):778-80. PubMed ID: 18683689
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
[TBL] [Abstract][Full Text] [Related]
20. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
